JPRN-UMIN000012254已完成1 期
A phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic adenocarcinoma - A phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic adenocarcinoma
Osaka Medical Center for Cancer and Cardiovascular Diseases Division of Hepatobiliary and Pancreatic Oncology0 个研究点目标入组 54 人开始时间: 2013年11月9日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Active infection 2.Lung fibrosis or intestinal pneumonia detectable on chest X-ray and CT 3.Severe complication (heart disease, cirrhosis, diabetes) 4.Myocardial infarction within 3 months 5.Active synchronous or metachronous malignancy 6.Pregnant or lactation women, or women with known or suspected pregnancy 7.Symptomatic brain metastasis 8.history of severe drug allergy 9.Peripheral neuropathy 10.Patients who are judged inappropriate for the entry into the study by the investigator
研究者
相似试验
已完成
不适用
Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancerunresectable locally advanced pancreatic cancerJPRN-UMIN000020475Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine24
已完成
不适用
Prospective study of chemoradiotherapy with gemcitabine and S-1 for borderline resectable or unresectable pancreatic cancerpancreatic cancerJPRN-UMIN000011453Multicenter Clinical Study Group of Osaka50
已完成
1 期
Phase I study of chemotherapy with gemcitabine, CDDP and S-1 for the patients with unresectable biliary tract cancerJPRN-UMIN000008415Jikei University School of Medicine24
已完成
1 期
A phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non-small cell lung canceron-small-cell lung cancerJPRN-UMIN000001234West Japan Oncology Group24
已完成
1 期
A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic CancerPancreatic CancerNCT02272738Osaka Medical Center for Cancer and Cardiovascular Diseases54